184 related articles for article (PubMed ID: 38003826)
21. Clinical, Virological, and Immunological Features in Cosmopolitan Genotype DENV-2-Infected Patients during a Large Dengue Outbreak in Sri Lanka in 2017.
Nwe KM; Ngwe Tun MM; Muthugala R; Nabeshima T; Balingit JC; Rajamanthri L; Jayawardana D; Attanayake S; Inoue S; Takamatsu Y; Urano T; Morita K
Am J Trop Med Hyg; 2023 Oct; 109(4):917-925. PubMed ID: 37696512
[TBL] [Abstract][Full Text] [Related]
22. Lower activation-induced T-cell apoptosis is related to the pathological immune response in secondary infection with hetero-serotype dengue virus.
Yang W; Yan H; Ma Y; Yu T; Guo H; Kuang Y; Ren R; Li J
Immunobiology; 2016 Mar; 221(3):432-9. PubMed ID: 26655144
[TBL] [Abstract][Full Text] [Related]
23. IFN-γ production depends on IL-12 and IL-18 combined action and mediates host resistance to dengue virus infection in a nitric oxide-dependent manner.
Fagundes CT; Costa VV; Cisalpino D; Amaral FA; Souza PR; Souza RS; Ryffel B; Vieira LQ; Silva TA; Atrasheuskaya A; Ignatyev G; Sousa LP; Souza DG; Teixeira MM
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1449. PubMed ID: 22206036
[TBL] [Abstract][Full Text] [Related]
24. Serotype-associated immune response and network immunoclusters in children and adults during acute Dengue virus infection.
Henrique Ferreira Sucupira P; Silveira Ferreira M; Santos Coutinho-da-Silva M; Alves Bicalho K; Carolina Campi-Azevedo A; Pedro Brito-de-Sousa J; Peruhype-Magalhães V; Rios M; Konduru K; Teixeira-Carvalho A; Grazziela Alves Coelho-Dos-Reis J; Ribeiro do Valle Antonelli L; Bortolo de Rezende V; Ludolf Ribeiro de Melo F; Couto Garcia C; Carla Silva-Andrade J; Artur da Costa-Rocha I; Alves da Rocha L; Aprigio Silva V; Damasceno Pinto S; Araújo de Melo S; Guimarães Costa A; de Souza Gomes M; Rodrigues Amaral L; Luiz Lima Bertarini P; Cristina da Silva Furtado E; Vieira Pinto da Silva E; Alves Ramos B; Barros Dos Santos É; Nazaré Oliveira Freitas M; Maria Caetano Faria A; Fernando da Costa Vasconcelos P; de Souza Bastos M; Carício Martins L; Assis Martins-Filho O; Sobreira Silva Araújo M
Cytokine; 2023 Sep; 169():156306. PubMed ID: 37542834
[TBL] [Abstract][Full Text] [Related]
25. Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue 1 infection among adult Chinese patients.
Tang Y; Kou Z; Zhang F; Yao X; Liu S; Ma J; Zhou Y; Zhao W; Tang X; Jin X
PLoS One; 2010 Dec; 5(12):e15631. PubMed ID: 21206915
[TBL] [Abstract][Full Text] [Related]
26. Elevated serum levels of high mobility group box 1 (HMGB1) protein in dengue-infected patients are associated with disease symptoms and secondary infection.
Allonso D; Belgrano FS; Calzada N; Guzmán MG; Vázquez S; Mohana-Borges R
J Clin Virol; 2012 Nov; 55(3):214-9. PubMed ID: 22884669
[TBL] [Abstract][Full Text] [Related]
27. Comparative cytokine profiling identifies common and unique serum cytokine responses in acute chikungunya and dengue virus infection.
Dhenni R; Yohan B; Alisjahbana B; Lucanus A; Riswari SF; Megawati D; Haryanto S; Gampamole D; Hayati RF; Sari K; Witari NPD; Myint KSA; Sasmono RT
BMC Infect Dis; 2021 Jul; 21(1):639. PubMed ID: 34215212
[TBL] [Abstract][Full Text] [Related]
28. Dynamics of interleukin-21 production during the clinical course of primary and secondary dengue virus infections.
Vivanco-Cid H; Maldonado-Rentería MJ; Sánchez-Vargas LA; Izaguirre-Hernández IY; Hernández-Flores KG; Remes-Ruiz R
Immunol Lett; 2014 Sep; 161(1):89-95. PubMed ID: 24858204
[TBL] [Abstract][Full Text] [Related]
29. Immune Response to Dengue Virus Infection in Pediatric Patients in New Delhi, India--Association of Viremia, Inflammatory Mediators and Monocytes with Disease Severity.
Singla M; Kar M; Sethi T; Kabra SK; Lodha R; Chandele A; Medigeshi GR
PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004497. PubMed ID: 26982706
[TBL] [Abstract][Full Text] [Related]
30. Acute-phase Serum Cytokine Levels and Correlation with Clinical Outcomes in Children and Adults with Primary and Secondary Dengue Virus Infection in Myanmar between 2017 and 2019.
Nwe KM; Ngwe Tun MM; Myat TW; Sheng Ng CF; Htun MM; Lin H; Hom NS; Soe AM; Elong Ngono A; Hamano S; Morita K; Thant KZ; Shresta S; Thu HM; Moi ML
Pathogens; 2022 May; 11(5):. PubMed ID: 35631079
[TBL] [Abstract][Full Text] [Related]
31. Detection of post-vaccination enhanced dengue virus infection in macaques: An improved model for early assessment of dengue vaccines.
Borges MB; Marchevsky RS; Carvalho Pereira R; da Silva Mendes Y; Almeida Mendes LG; Diniz-Mendes L; Cruz MA; Tahmaoui O; Baudart S; Freire M; Homma A; Schneider-Ohrum K; Vaughn DW; Vanloubbeeck Y; Lorin C; Malice MP; Caride E; Warter L
PLoS Pathog; 2019 Apr; 15(4):e1007721. PubMed ID: 31009499
[TBL] [Abstract][Full Text] [Related]
32. Serum levels of soluble vascular cell adhesion molecules may correlate with the severity of dengue virus-1 infection in adults.
Liao B; Tang Y; Hu F; Zhou W; Yao X; Hong W; Wang J; Zhang X; Tang X; Zhang F
Emerg Microbes Infect; 2015 Apr; 4(4):e24. PubMed ID: 26421267
[TBL] [Abstract][Full Text] [Related]
33. Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines.
Züst R; Toh YX; Valdés I; Cerny D; Heinrich J; Hermida L; Marcos E; Guillén G; Kalinke U; Shi PY; Fink K
J Virol; 2014 Jul; 88(13):7276-85. PubMed ID: 24741106
[TBL] [Abstract][Full Text] [Related]
34. Cepharanthine inhibits dengue virus production and cytokine secretion.
Phumesin P; Panaampon J; Kariya R; Limjindaporn T; Yenchitsomanus PT; Okada S
Virus Res; 2023 Feb; 325():199030. PubMed ID: 36587870
[TBL] [Abstract][Full Text] [Related]
35. DENV-specific IgA contributes protective and non-pathologic function during antibody-dependent enhancement of DENV infection.
Wegman AD; Waldran MJ; Bahr LE; Lu JQ; Baxter KE; Thomas SJ; Waickman AT
PLoS Pathog; 2023 Aug; 19(8):e1011616. PubMed ID: 37639455
[TBL] [Abstract][Full Text] [Related]
36. Innate Lymphoid Cells Activation and Transcriptomic Changes in Response to Human Dengue Infection.
Poonpanichakul T; Chan-In W; Opasawatchai A; Loison F; Matangkasombut O; Charoensawan V; Matangkasombut P;
Front Immunol; 2021; 12():599805. PubMed ID: 34079535
[TBL] [Abstract][Full Text] [Related]
37. Dengue viremia kinetics in asymptomatic and symptomatic infection.
Matangkasombut P; Manopwisedjaroen K; Pitabut N; Thaloengsok S; Suraamornkul S; Yingtaweesak T; Duong V; Sakuntabhai A; Paul R; Singhasivanon P
Int J Infect Dis; 2020 Dec; 101():90-97. PubMed ID: 32992011
[TBL] [Abstract][Full Text] [Related]
38. Symptoms and Immune Markers in Plasmodium/Dengue Virus Co-infection Compared with Mono-infection with Either in Peru.
Halsey ES; Baldeviano GC; Edgel KA; Vilcarromero S; Sihuincha M; Lescano AG
PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004646. PubMed ID: 27128316
[TBL] [Abstract][Full Text] [Related]
39. Co-circulation of dengue virus serotypes in Central India: Evidence of prolonged viremia in DENV-2.
Agarwal A; Gupta S; Chincholkar T; Singh V; Umare IK; Ansari K; Paliya S; Yadav AK; Chowdhary R; Purwar S; Biswas D
Infect Genet Evol; 2019 Jun; 70():72-79. PubMed ID: 30798036
[TBL] [Abstract][Full Text] [Related]
40. Clinical, Virological, and Immunological Profiles of DENV, ZIKV, and/or CHIKV-Infected Brazilian Patients.
Sánchez-Arcila JC; Badolato-Correa J; de Souza TMA; Paiva IA; Barbosa LS; Nunes PCG; Lima MDRQ; Dos Santos FB; Damasco PV; da Cunha RV; Azeredo EL; de Oliveira-Pinto LM
Intervirology; 2020; 63(1-6):33-45. PubMed ID: 32966990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
